Dr. Kan Nim Chi Amanda - Pathology
Specialist in Pathology
Highlights
- MCHK RegisteredVerified
- Specialist in PathologyBachelor of Medicine and Bachelor of Surgery (MBChB) · The Hong Kong College of Pathologists · Medical degree 1999
- InsuranceBeing compiled｜See details
About
Dr. Kan Nim Chi Amanda is a registered Pathology specialist in Hong Kong.
Education
Specialist in Pathology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)1999
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Kan Nim Chi Amanda? Claim page and update insurance →
FAQ
Is Dr. Kan Nim Chi Amanda any good?
Dr. Kan Nim Chi Amanda is a registered Pathology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Kan Nim Chi Amanda do?
Dr. Kan Nim Chi Amanda practises in Pathology.
Are you Dr. Kan Nim Chi Amanda? Claim this page to update and manage.
ClaimResearch and publications
6 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- CT-guided bone biopsies with non-diagnostic results in pediatric patients-a multi-institutional 10-year retrospective review.European radiology · 2026
- Rare Pediatric Cerebellar High-Grade Gliomas Mimic Medulloblastomas Histologically and Transcriptomically and Show p53 Mutations.Cancers · 2024
- Implementation of Public Funded Genome Sequencing in Evaluation of Fetal Structural Anomalies.Genes · 2022
- Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.Pediatric transplantation · 2022
- Clinical and pathological characterization of FLNC-related myofibrillar myopathy caused by founder variant c.8129G>A in Hong Kong Chinese.Clinical genetics · 2020
- Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society · 2014
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer